Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab. [electronic resource]
Producer: 20120615Description: 114-22 p. digitalISSN:- 1555-8576
- Animals
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antigens, CD20 -- genetics
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Burkitt Lymphoma -- drug therapy
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Depsipeptides -- administration & dosage
- Female
- Humans
- Immunophenotyping
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Mice
- Mice, Nude
- Peptides, Cyclic
- Rituximab
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.